HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
Cargill T., Cicconi P., Brown A., Holland L., Karanth B., Rutkowski K., Ashwin E., Mehta R., Chinnakannan S., Sebastian S., Bussey L., Sorensen H., Klenerman P., Evans T., Barnes E.